BOL Pharma is a leading producer of medicinal cannabis-based products. The company has provided thousands of patients with medicinal cannabis for a wide range of medical indications. BOL Pharma is positioned as the largest producer in Israel and one of the largest globally.
BOL Pharma’s facilities comply with international and Israel Medical Cannabis Agency (IMC) protocols including: GAP (agriculture), GSP (security), GMP (manufacturing), and GDP (delivery). The company intends to expand marketing capabilities to geographies around the world including Europe, North and South America, and the Pacific.
FDA and EMA approved drug development is at the center of BOL Pharma’s value proposition. The company is committed to bringing Phyto cannabinoid pharmaceuticals by conducting clinical research on formulations of pure cannabinoids combined with sophisticated drug delivery technologies.